Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Roger_Jeffs
|
| gptkbp:collaboratedWith |
gptkb:Gilead_Sciences
GlaxoSmithKline |
| gptkbp:focusesOn |
drug delivery
rare diseases |
| gptkbp:foundedYear |
2004
|
| gptkbp:founder |
gptkb:Joseph_DeSimone
|
| gptkbp:headquartersLocation |
gptkb:Morrisville,_North_Carolina,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Liquidia Corporation
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:LIQ861
LIQ865 |
| gptkbp:numberOfEmployees |
approximately 100 (as of 2023)
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:servesArea |
gptkb:United_States
|
| gptkbp:specializesIn |
inhaled therapies
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:LQDA
|
| gptkbp:technology |
PRINT (Particle Replication In Non-wetting Templates)
|
| gptkbp:website |
https://liquidia.com
|
| gptkbp:bfsParent |
gptkb:LQDA
|
| gptkbp:bfsLayer |
8
|